SCHEMBL24061013

SCHEMBL24061013

Cc1ccc(-c2ccc(C(=O)NCCCN(C)C)cc2)cc1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 3/20 0.65
▸ L3MBTL1 Q9Y468 3/20 0.59
▸ MAPK14 Q16539 1/20 0.58
▸ KDM4E B2RXH2 4/20 0.56
▸ TET3 O43151 1/20 0.56
▸ TET2 Q6N021 1/20 0.56
▸ TET1 Q8NFU7 1/20 0.56
▸ POLB P06746 2/20 0.55
▸ LMNA P02545 1/20 0.55
▸ SMN1; SMN2 Q16637 3/20 0.54
▸ HTT P42858 2/20 0.54
▸ NPC1 O15118 2/20 0.54
▸ ALDH1A1 P00352 2/20 0.54
▸ RAB9A P51151 2/20 0.54
▸ MAPT P10636 1/20 0.54
▸ AGTR1 P30556 1/20 0.54
▸ NPSR1 Q6W5P4 1/20 0.54
▸ THRA P10827 1/20 0.53
▸ THRB P10828 1/20 0.53
▸ MEN1 O00255 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2120449 0.95 HPGD (0.70) HPGDL3MBTL1MAPK14KDM4EPOLB
SCHEMBL14679111 0.91 L3MBTL1 (0.67) HPGDL3MBTL1POLBLMNASMN1; SMN2
SCHEMBL11966135 0.89 L3MBTL1 (0.69) HPGDL3MBTL1POLBLMNASMN1; SMN2
SCHEMBL10020214 0.89 HPGD (0.79) HPGDL3MBTL1MAPK14KDM4EPOLB
SCHEMBL24061104 0.86 FYN (0.59) HPGDL3MBTL1MAPK14KDM4ETET3
SCHEMBL24061011 0.86 PTAFR (0.59) HPGDL3MBTL1MAPK14KDM4ETET3
SCHEMBL6207528 0.85 SMN1; SMN2 (0.67) HPGDL3MBTL1KDM4EPOLBLMNA
SCHEMBL12640646 0.85 HPGD (0.52) HPGDL3MBTL1MAPK14KDM4ETET3
SCHEMBL26378192 0.84 HPGD (0.92) HPGDL3MBTL1MAPK14KDM4ETET3
SCHEMBL8411545 0.83 HPGD (0.70) HPGDL3MBTL1KDM4ESMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021239727-A1 4-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)-3,6-DIHYDROPYRIDINE-1-(2H)-CARBOXAMIDE DERIVATIVES AS LIMK AND/OR ROCK KINASES INHIBITORS FOR USE IN THE TREATMENT OF CANCER CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2021-12-02 — — WO disclosed
EP-3915990-A1 4-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)-3,6-DIHYDROPYRIDINE-1-(2H)-CARBOXAMIDE DERIVATIVES AS LIMK AND/OR ROCK KINASES INHIBITORS FOR USE IN THE TREATMENT OF CANCER Centre National de la Recherche Scientifique (FR) 2021-12-01 — — EP disclosed
Send feedback